PubRank

Kaoru Tateno

Author PubWeight™ 30.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007 4.63
2 Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J 2004 2.50
3 Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arterioscler Thromb Vasc Biol 2012 1.75
4 Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ Res 2006 1.68
5 Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 2003 1.67
6 Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2006 1.44
7 Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 2009 1.43
8 Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J Clin Invest 2010 1.34
9 Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circ Cardiovasc Interv 2009 1.30
10 Reduced nitric oxide causes age-associated impairment of circadian rhythmicity. Circ Res 2008 1.06
11 Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt. Circ Res 2008 1.04
12 Vascular cell senescence and vascular aging. J Mol Cell Cardiol 2004 1.04
13 p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab 2012 1.02
14 Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med 2009 1.01
15 Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis. Circ Res 2009 0.98
16 Akt-induced cellular senescence: implication for human disease. Cell Cycle 2004 0.93
17 Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? Lancet 2002 0.91
18 Notch activation mediates angiotensin II-induced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells. Hypertens Res 2013 0.91
19 Role of Jagged1 in arterial lesions after vascular injury. Arterioscler Thromb Vasc Biol 2011 0.82
20 The role of vascular cell senescence in atherosclerosis: antisenescence as a novel therapeutic strategy for vascular aging. Curr Vasc Pharmacol 2004 0.81
21 Usefulness of rapid quantitative measurement of myoglobin and troponin T in early diagnosis of acute myocardial infarction. Circ J 2004 0.80
22 In vivo tracking of transplanted mononuclear cells using manganese-enhanced magnetic resonance imaging (MEMRI). PLoS One 2011 0.79
23 Cardiac sarcoidosis evaluated by multimodality imaging. Int J Cardiol 2010 0.78
24 Steroid-responsive thromboangiitis obliterans. Lancet 2004 0.75